BSH committee vacancies
Volunteers play a crucial role in helping to deliver the Society's charitable objectives. We have a wide range of opportunities for those who wish to get involved in BSH's activities.
The benefits of volunteering include
- Helping us to fulfil our mission of transforming patient care through excellence in haematology
- Getting involved with interesting projects
- Meeting and networking with peers
- Using your knowledge to help others
- Learning new skills
Please be aware that Committee vacancies are only open to BSH members.
BSH is seeking to appoint a Consultant BSH Member to join our Communications Committee.
The Communications Committee is a small group of dedicated volunteers that span the diverse nature of the haematology specialty. The committee supports the development and implementation of the BSH communications strategy as well as advising BSH administrative staff on relevant and informative content for the society’s communications channels.
The role requires monthly 30-minute teleconference calls with the committee and staff, as well as bi-annual committee meetings at the BSH London office. It also involves advisory work on BSH projects such as the Annual Scientific Meeting and the upcoming BSH 60th anniversary celebrations for 2020. The role will require between 1-2 hours a month.
This is an ideal opportunity to help play your part in shaping the direction of the BSH and is a great way to advance your career in the haematology specialty. No specialist skills are required, however an appreciation and understanding of social media would be an advantage.
BSH membership is highly desirable, however we will consider applications from non-members if they demonstrate skills and experience that would suit this role.
To apply please send your CV and a short covering letter detailing what you would bring to the role and any relevant skills and experience to firstname.lastname@example.org
Deadline: 29 September 2019
The Haematology-Oncology Task Force of the British Society for Haematology Guidelines (BSH Guidelines) requires two new members.
The appointments will be for 3 years in the first instance. Applications are requested from consultant haematologists or clinical scientists involved in Haemato-Oncology with a specialty of Leukaemia, Myeloma and Myelodysplastic syndrome (MDS). You will need to be working in a UK hospital and interested in joining the Task Force.
The Task Force meet 3 times annually at the BSH offices in London. The work of the taskforce is mostly in producing and updating guidelines and addressing other areas of development relevant to the UK. Being part of this group offers an excellent opportunity to help advance a career.
To register your interest please send your CV and covering letter to Rita Gupta, BSH Guidelines Programme Manager: email@example.com by Monday 21 October 2019.
BSH is funding plenary speakers for haematology and transfusion conferences in low-to-middle income countries (LMIC). The aim is to foster partnerships between the BSH and other haematology societies to share knowledge and expertise. During the pilot scheme in 2017/18, BSH selected speakers for conferences in Ghana, Kenya, Egypt and Thailand, with a number of collaborative projects subsequently arising in education, research, and capacity building. Following these successes, BSH is expanding the scheme for 2019/20.
The SIG is looking for a trainee or consultant haematologist to join the two existing Task Force members to help with selecting applicant LMIC societies and speakers, to liaise between them, and to contribute to providing feedback on the scheme to the BSH.
The time commitment is small; a few hours per month. The Task Force collaborates predominantly through email and phone calls, and the wider SIG meets quarterly.
Please send an email briefly detailing your interest in joining the Task Force and any relevant experience, along with CV, to firstname.lastname@example.org
The BSH Finance Audit and Risk Committee has two vacancies for members looking for a slightly different learning experience and career development. The Committee oversees the annual financial audit of the BSH as well as the BSHE; its investments, and monitors spending against budgets. We don’t require specialist knowledge, but we do look for people who will ask questions! We would particularly like to encourage a diverse range of applications: e.g. from younger members; from members who are not medics and from different ethnic backgrounds.
Please email the CEO, katy Amberley, a brief statement outlining your interest and what you could bring to the committee to: email@example.com
The BSH Nominations and Governance Committee has four vacancies for members interested in ensuring not only that potential future board members are being identified and developed, but also that there is adequate ‘bench strength’ in management to run key parts of the company in accordance with appropriate corporate governance standards.
We would particularly like to encourage a diverse range of applications: e.g. from younger members; from members who are not medics and from different ethnic backgrounds.
Please email the CEO, Katy Amberley, a brief statement outlining your interest and what you could bring to the committee to: Katy@b-s-h.org.uk
The Royal College of Pathologists is seeking to recruit new audit evaluators for haematology.
Applicants should be Fellows of the College, have knowledge of the clinical audit process and be experienced in undertaking high-quality clinical audit. Evaluators are responsible for evaluating whether the criteria and standards of audits for certification are met appropriately for your own specialty.
To apply please submit an abridged CV, one of your own audit reports, and a statement in support of your application (no more than 500 words), explaining how your skills and experience meet the person specification and how you would approach the role if appointed.
For further information and to apply for the role, please contact Kate Stewart at firstname.lastname@example.org.
University of Toronto Fellowship in Complement-Mediated Diseases & Apheresis
The University of Toronto Division of Hematology is offering a new two-year clinical fellowship from July 2020 in complement-mediated diseases and apheresis. Training will occur across multiple UofT-affiliated hospitals, including the Toronto General Hospital, St. Michael’s Hospital, and The Hospital for Sick Children. Clinical exposure will be via specialty clinics (e.g. PNH, TMA, C3G, GN), consult services, and time in the apheresis unit. Specialist laboratory exposure will also be provided, including translational complement labs and histocompatibility lab. Further experience may be gained in other centres of expertise, and by attendance at relevant local, national, and international congresses.
There will be a general expectation for the fellow to undertake a graduate degree in an area related to the clinical work unless previously obtained. (E.g. clinical epidemiology/health research methods, biomedical science, education, QI). Significant protected research time is set aside in both years for scholarly projects. Fellows are expected to successfully complete at least one peer-reviewed publication during the fellowship.
The fellowship is fully funded to provide fellow’s salary and graduate tuition, and travel to relevant meetings. Applications are invited from physicians who would have completed adult or pediatric training in either hematology or nephrology at the time of commencing the fellowship.
Date & Requirements
Deadline for application is 31 August 2019. Interested applicants should submit a letter of intent, a current curriculum vitae, and a list of three references. Applicants must have passed or be eligible for independent licensing in Ontario, or must be eligible for an educational license (minimum four years residency training following medical school). Outstanding applicants with equivalent training in other medical systems are also encouraged to apply. Please submit all documents by email to Christine.Andrews@uhn.ca.
The NC3Rs CRACK IT Challenges launch event to showcase the 2019 Challenges will take place on 11 September in central London.
▪ Challenge 32 Transgene Track: Development of a sensitive, absolute quantification method for tracking AAV gene therapies and CAR-T cells in vivo. (Two Phase Challenge Sponsored by GSK and Novartis).
▪ Challenge 33 CleanCut: Animal free tumourigenicity assessment of genome edited human haematopoietic stem cells. (Two Phase Challenge Sponsored by Novartis, Bayer and Takeda).
▪ Challenge 34 Sharp and to the Point: Developing needles for high throughput and critical compound administration in mice. (Single Phase Challenge Sponsored by AstraZeneca, GSK, The University of Sheffield and The Royal Veterinary College).
The Challenge briefs describing the Challenges, deliverables, in-kind contributions from the Sponsors and budgets is available now on the NC3Rs Innovation Platform.
▪ Each of the Two Phase Challenges offers up to £1 million funding and a research contract for up to three years.
▪ The Single Phase Challenge offers up to £100k funding and a research contract for up to one year.
To find out more about the Challenges, meet the Sponsors and potential collaborators, and find out what makes a good application, you should attend the CRACK IT Challenges 2019 launch event on 11 September 2019 in central London. The launch event is free to attend but registration is essential.
To register, please download and complete the registration form on the NC3Rs Innovation Platform. The deadline for registration is 4 September 2019.
Furthermore, to have the opportunity to give a Lightning Talk on the Challenge of interest at the launch event, please let us know by Wednesday, 28 August 2019. More information can be found on the NC3Rs Innovation Platform.
CRACK IT Challenges is a research competition to solve scientific and business problems identified by the bioscience sector. The Challenges are designed to reduce the reliance on animal models and/or improve animal welfare and lead to the development of marketable products. The CRACK IT Two Phase Challenges competition is run using the SBRI process which is supported by Innovate UK and Challenges are sponsored by companies who provide in-kind contributions such as data, validation and expertise.
Projects, consultations and research
The Academic Section of Vascular Surgery at Imperial College London are conducting a survey evaluating the impact of the Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT) Trial on clinical practice. They would be grateful if you could spare 3 to 5 minutes to share your experience.
Link to the survey: ATTRACT Trial Survey
Please direct any questions or comments regarding the questionnaire to Aleksandra Staniszewska (email@example.com).
We are gathering nationwide data for a report which will offer insights into the status of the UK’s clinical haematology workforce. This report will benefit haematology professional and patients.
We are also looking for 7 haematology professionals to participate in phone interviews lasting up to 40 minutes, the information from the phone interviews will be anonymised.
We are under represented in Scotland and Northern Ireland so particularly keen to hear from those in these areas.
We are looking for
- Service Leads / Heads of Department, to comment on variation of job plans;
- Two NHS Medical / Clinical Directors, to comment on removal of trainees from job plans;
- A senior consultants who have recently resigned to take up a role elsewhere, to comment on the reasons for this, and whether they have seen colleagues following a similar path;
- A nurse
If you would be willing to be interviewed please contact Saskia Ottignon at Saskia@b-s-h.org.uk
Are you a health professional working with people with blood cancer in the UK?
Please consider taking part in this questionnaire about physical activity during and after blood cancer treatment
Health Professionals (HPs) can play a part in promoting appropriate physical activity before, during and after cancer treatment. However, most of the research in this important topic has been carried out with HPs predominately working with patients with solid tumours, such as breast, colorectal and prostate cancer. There is limited evidence on the opinions of HPs working in haemto-oncology on physical activity guidelines for patients undergoing active treatment for blood cancers and their perceptions of what physical activity or exercise patients should do as part of, during or after their treatment. There is no published research solely focused on haemato-oncology HPs. We are seeking to gain insights on this topic from health professionals working with people with blood cancers, including doctors, nurses, allied health professionals and support workers, via this brief online survey.
The survey takes approximately 10 minutes to complete, and you can only access the link once, so remember to click 'Save' if you need to leave and return to the survey before completion.